Vertex Pharmaceuticals (VRTX) Asset Utilization Ratio (2010 - 2026)
Vertex Pharmaceuticals (VRTX) posted quarterly Asset Utilization Ratio of 0.47 for Q1 2026, down 4.1% year-over-year from 0.49 in Q1 2025, and down 1.36% quarter-over-quarter from 0.48 in Q4 2025.
Vertex Pharmaceuticals (VRTX) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
Vertex Pharmaceuticals' Asset Utilization Ratio history runs 17 years deep, the most recent figure standing at 0.47 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 4.1% year-over-year to 0.47; the TTM figure through Mar 2026 stood at 0.47 (down 4.1% YoY), while the FY2025 annual figure was 0.5, up 2.32% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.47, down from 0.48 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.57 in Q1 2022, with the low at 0.44 in Q1 2024.
- The 5-year median for Asset Utilization Ratio is 0.49 (2025), against an average of 0.49.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio decreased 14.85% in 2023, then increased 11.94% in 2025.
- Vertex Pharmaceuticals' Asset Utilization Ratio stood at 0.51 in 2022, then fell by 13.35% to 0.44 in 2023, then advanced by 10.87% to 0.49 in 2024, then declined by 3.46% to 0.48 in 2025, then slipped by 1.36% to 0.47 in 2026.
- Business Quant data shows VRTX's Asset Utilization Ratio at 0.47 in Q1 2026, 0.48 in Q4 2025, and 0.48 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.47 |
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.48 |
| Sep 30, 2025 | 0.48 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 0.49 |
| Dec 31, 2024 | 0.49 |
| Sep 30, 2024 | 0.50 |
| Jun 30, 2024 | 0.47 |
| Mar 31, 2024 | 0.44 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.46 |
| Jun 30, 2023 | 0.48 |
| Mar 31, 2023 | 0.50 |
| Dec 31, 2022 | 0.51 |
| Sep 30, 2022 | 0.54 |
| Jun 30, 2022 | 0.56 |
| Mar 31, 2022 | 0.57 |
| Dec 31, 2021 | 0.58 |
| Sep 30, 2021 | 0.57 |